BIOLASE Announces a Pilot program with Einstein Healthcare Network’s Residency in Endodontic

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

March 30, 2021

BIOLASE notes the goal of the program is to offer residents hands-on experience with dental lasers that are already in use across the industry, allowing residents to immediately implement their training when joining a future practice.

“BIOLASE has a deep commitment to the endodontic specialty,” said John Beaver, President and CEO of BIOLASE. “It is important for us to live out our mission of advancing dentistry by empowering the next generation of endodontists from Einstein. We are honored to be part of not only the residents’ future careers by arming them with innovative technologies, but also the future relationships they will build with their patients by offering a less invasive and more positive experience.”

Einstein Healthcare Network’s residency in endodontics is one of the first hospital-based endodontic programs approved by the American Dental Association. The residency is a 24-month program that admits two residents each year, preparing graduates to practice, teach and conduct independent research.

“We are committed to actively seeking out ways to help our residents feel fully equipped to enter into endodontic practice after leaving our program,” said Frederic Barnett, DMD, Chairman of the Department of Dental Medicine, and Chair and Program Director of Postdoctoral Endodontics at Albert Einstein Medical Center in Philadelphia. “Partnering with BIOLASE to integrate laser assisted endodontic training early on in our residents’ careers allows us to tighten the learning curve, which can positively impact a practice’s bottom line and ultimately provide a better patient experience overall.”

The Waterlase dental laser offers various benefits for endodontists, from faster procedures to new treatment options. Educating endodontists about the benefits of dental lasers is part of BIOLASE’s continued effort to help improve patient experiences and outcomes. This announcement comes on the heels of the recently developed Waterlase Endo Academy, open to all Waterlase endodontists. Learn more about the benefits of laser dentistry in endodontics at biolase.com/betterendo.

spot_img

DON'T MISS

Related Articles